ABSTRACT
Cytologic features such as the shape and size of tumor cells can predict metastatic death in uveal melanoma and other cancers but suffer from poor reproducibility. In this study, we investigate the interobserver concordance of digital morphometry, and correlate the results with BRCA associated protein-1 (BAP-1) expression and BAP-1 gene mutation status, monosomy 3, gene expression classifications and patient survival in uveal melanoma. The average number of cells analyzed in each of 107 tumors, was 1957 (SD 349). Mean time consumption was less than 2.5 minutes per tumor. Identical morphometric classification was obtained for ≥ 85 % of tumors in all twelve evaluated morphometric variables (κ 0.70–0.93). The mean nucleus area, nucleus perimeter, nucleus max caliper and nucleus to cell area ratio were significantly greater in tumors with low BAP-1 expression and gene expression class 2. Patients had significantly shorter survival if their tumors had low BAP-1 (Log-Rank p=0.002), gene expression class 2 (p=0.004), long nucleus perimeters (p=0.031), long nucleus max calipers (p=0.029) and high mean nucleus to cell area ratios (p=0.041) as defined in a training cohort and then tested in a validation cohort. In the validation cohort, long nucleus perimeters and long nucleus max calipers correlated with monosomy 3 (Pearson Chi-Square p=0.006 and p=0.009, respectively). Long nucleus perimeters also correlated with BAP-1 mutation (p=0.017). We conclude that digital morphometry can be fast and highly reproducible, that for the first time, morphometry parameters can be objectively quantitated in thousands of cells at a time in sub-μm resolutions, and that variables describing the shape and size tumor nuclei correlate to BAP-1 status, monosomy 3, gene expression class as well as patient survival.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by Karolinska Institutet (Karolinska Institutets stiftelsemedel för ögonforskning), the Swedish Society of Medicine (Cronqvists stiftelse) and Stockholm County Council (Stockholms läns landsting).
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Not Applicable
Data Availability
The results published here are in part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga. All data analyzed during this study are included in this published article. The raw datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
